COVID Vaccines (COVID)

In partnership with the Asian Development Bank, IVAC summarized the evidence for COVID-19 vaccine performance against Omicron sub-variants.

These forest plots summarize the available evidence on the vaccine effectiveness of the bivalent Omicron-containing mRNA COVID-19 vaccines.

This document provides an overview of the available laboratory evidence on the ability of the bivalent Omicron-containing mRNA COVID-19 vaccines to neutralize Omicron subvariants.

In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.

In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.

In partnership with the Asian Development Bank, IVAC summarized the landscape, benefits, and challenges of next generation COVID-19 vaccines.

This table provides a summary of studies on the duration of protection of COVID-19 vaccines. This table is updated weekly.

In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.

In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.

In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.